Thibault, C., Bennamoun, M., Fléchon, A., Gravis, G., Pouessel, D., Combe, P., Borchiellini, D., Loriot, Y., Laguerre, B., Barthélémy, P., Huillard, O., Gross-Goupil, M., Roy, A. L., Jaffrelot, L., Cancel, M., Audenet, F., Belhouari, H., Kaci, G., Lepicard, E., Vernerey, D., Henriques, J., Oudard, S. (2026). Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-03045